Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.026 SGD | -13.33% | -49.02% | -10.34% |
Feb. 22 | Asia Vets Widens H2 Attributable Loss Amid Increased Spending | MT |
Feb. 21 | Asia Vets Holdings Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 27.79 | 18.06 | 9.864 | 11.84 | 7.307 | 4.238 |
Enterprise Value (EV) 1 | 15.84 | 6.114 | -2.842 | 1.162 | -2.486 | -4.621 |
P/E ratio | -11.2 x | 24.1 x | 789 x | -42.4 x | -9.53 x | -5.69 x |
Yield | - | - | 2.82% | - | - | - |
Capitalization / Revenue | 19 x | 4.74 x | 2.28 x | 3.86 x | 3.02 x | 1.82 x |
EV / Revenue | 10.9 x | 1.61 x | -0.66 x | 0.38 x | -1.03 x | -1.99 x |
EV / EBITDA | -35.1 x | 33.1 x | -7.42 x | -3.31 x | 3.18 x | 6.86 x |
EV / FCF | 0.87 x | 15.7 x | -1.18 x | -0.59 x | 4.11 x | 7.46 x |
FCF Yield | 115% | 6.38% | -85% | -169% | 24.3% | 13.4% |
Price to Book | 1.49 x | 0.93 x | 0.51 x | 0.61 x | 0.39 x | 0.24 x |
Nbr of stocks (in thousands) | 138,928 | 138,928 | 138,928 | 146,146 | 146,146 | 146,146 |
Reference price 2 | 0.2000 | 0.1300 | 0.0710 | 0.0810 | 0.0500 | 0.0290 |
Announcement Date | 4/9/19 | 4/9/20 | 4/12/21 | 4/8/22 | 4/10/23 | 4/8/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 1.459 | 3.808 | 4.323 | 3.066 | 2.421 | 2.326 |
EBITDA 1 | -0.4508 | 0.1846 | 0.3828 | -0.3507 | -0.7827 | -0.6738 |
EBIT 1 | -0.5035 | 0.0486 | 0.2507 | -0.4432 | -0.8671 | -0.7287 |
Operating Margin | -34.51% | 1.28% | 5.8% | -14.46% | -35.81% | -31.33% |
Earnings before Tax (EBT) 1 | -2.314 | 0.7887 | 0.0858 | -0.2951 | -0.7785 | -0.7443 |
Net income 1 | -2.335 | 0.7698 | 0.0125 | -0.2769 | -0.767 | -0.7443 |
Net margin | -160.04% | 20.22% | 0.29% | -9.03% | -31.67% | -32% |
EPS 2 | -0.0178 | 0.005399 | 0.000090 | -0.001912 | -0.005247 | -0.005100 |
Free Cash Flow 1 | 18.19 | 0.3901 | 2.414 | -1.961 | -0.6044 | -0.6193 |
FCF margin | 1,247.01% | 10.24% | 55.84% | -63.98% | -24.96% | -26.63% |
FCF Conversion (EBITDA) | - | 211.28% | 630.65% | - | - | - |
FCF Conversion (Net income) | - | 50.67% | 19,305.71% | - | - | - |
Dividend per Share | - | - | 0.002000 | - | - | - |
Announcement Date | 4/9/19 | 4/9/20 | 4/12/21 | 4/8/22 | 4/10/23 | 4/8/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 11.9 | 11.9 | 12.7 | 10.7 | 9.79 | 8.86 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 18.2 | 0.39 | 2.41 | -1.96 | -0.6 | -0.62 |
ROE (net income / shareholders' equity) | -12.8% | 4.06% | 0.06% | -1.43% | -4.04% | -4.09% |
ROA (Net income/ Total Assets) | -1.6% | 0.14% | 0.72% | -1.31% | -2.73% | -2.4% |
Assets 1 | 146.1 | 539.8 | 1.744 | 21.2 | 28.06 | 31.04 |
Book Value Per Share 2 | 0.1300 | 0.1400 | 0.1400 | 0.1300 | 0.1300 | 0.1200 |
Cash Flow per Share 2 | 0.0900 | 0.0900 | 0.0900 | 0.0800 | 0.0700 | 0.0600 |
Capex 1 | 0.02 | 0 | 0.07 | 0.02 | 0.06 | 0.06 |
Capex / Sales | 1.07% | 0.08% | 1.51% | 0.59% | 2.3% | 2.71% |
Announcement Date | 4/9/19 | 4/9/20 | 4/12/21 | 4/8/22 | 4/10/23 | 4/8/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.34% | 2.79M | |
-30.32% | 130M |
- Stock Market
- Equities
- 5RE Stock
- Financials Asia Vets Holdings Ltd.